McKinsey April 2, 2024
Sarun Charumilind, Katherine Han, Jeff Ruff, Amit Shah, Isaac Swaiman

Price transparency is one of several industry innovations that is increasing the potential for consumerism in US healthcare.

It has been more than a year and a half and three years, respectively, since federal price transparency rules went into effect for payers and hospitals. Together, the two rules require public disclosure of all commercial payer–provider negotiated rates, and they include other provisions aimed at improving price transparency.

After a slow start, payers and hospitals have made progress toward publishing negotiated rates. In the meantime, regulators are continuing to take actions to further advance price transparency. For example, the Centers for Medicare & Medicaid Services (CMS) has shortened the time hospitals have to respond to notices of noncompliance and has imposed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Payer, Pricing / Spending, Provider
Repeated Reimbursement Haircuts From CMS Won’t Bend The Cost Curve
Hospitals Merge For Power, While ‘Price Transparency’ Fantasy Persists
Home Health: A Solution to Skyrocketing Healthcare Costs
FTC Chief Says Tech Advancements Risk Healthcare Price Fixing
Hospital mergers are leading to higher prices. Will regulators step in?

Share This Article